Table 1.
Author | City, country | Period | Number | Age | Gender | Comorbidity | Race | IMC kg/m2 |
Whittaker et al3 | London, UK | 23 March and 16 May | 58 | 9 years (IQR 5.7–14) | 43% boys | 7/58 comorbidities | 69% black or Asian | N/R |
Riphagen et al6 | London, UK | 10 days in mid-April | 8 | 4–14 years (range) |
5/8 boy | None | 6/8 Afro-Caribbean | 14–33 7/8 > 75th centile/weight |
Verdoni et al7 | Bergamo, Italy | 18 February and 20 April | 10 | 7.5 years (SD 3–5) | 7/10 boys | N/R | N/R | N/R |
Belhadjer et al8 | France (12 hospitals) and Switzerland (one hospital) | 22 March–30 April | 35 | 10 years (IQR 8.2–12.4) | 51% boys | Comorbidities 28% (asthma 8.55; lupus 3%) | N/R | Overweight 17% |
Golfred-Cato et al13 | Multicentre US | 1 March–29 July | 570 | 8 (IQR 4–12) | 55.4% boys | Comorbidities 8% | 40.5% Hispanic and 33.1% black non-hispanic | Obesity 25.6% |
Cheung et al33 | New York, USA | 18 April and 5 May | 17 | 8 years (IQR 1.8–16) | 47% boys | Most were previously healthy (mild asthma in 3) | White 70% | N/R |
Kaushik et al38 | New York, USA | 23 April–23 May | 33 | 10 years (IQR 6–13) | 61% boys | Comorbidities 48% |
45% Hispanic/latino 39% black |
Overweight 12% Obesity (BMI >30 kg/m2) 6% |
Ramcharan et al40 | UK | 10 April and 9 May | 15 | 8.8 (IQR 6.4–11.2) 93% were over 5 years |
73% boys | 100% African/Afro-Caribbean (40%), South Asian, (40%) Mixed (13%) or other monority ethnic | ||
Toubiana et al45 | Paris, France | 27 April and 11 May | 21 children with features of Kawasaki disease | 7.9 years (IQR 3.7–16.6) | 43% boys | N/R | 57% sub-Saharan Africa/Caribbean islands | 76% had a BMI below the 97th centile |
Pouletty et al46 | Paris, France | Since April 2020 | 16 | 10 (IQR 4.7–12.5) | 50% boys | Comorbidities 37% |
N/R | Overweight 25% |
Capone et al47 | New York, USA | 17 April–13 May | 33 | 8.6 years (IQR 5.5–12.6) | 61% boys | Comorbidities 21% | 73% non-Hispanic | Overweight 6% Obese 39% |
Feldstein et al48 | Multicentre, USA | 15 March–20 May | 186 | 8.3 years (IQR 3.3–12.5) | 62% boys | Comorbidities 27% | 31% Hispanic, 25% black non- Hispanic | Obesity 29% |
Dufort et al49 | New York City | 1 March–10 May | 95 | 0–5 years (31%) 6–12 years (42%) 13–20 years (27%) |
54% boys | Comorbidities 64% | 40% Black 36% Hispanic |
Obesity 29% |
BMI, body mass index; N/R, not reported; PIMS-TS, paediatric inflammatory multisystem syndrome temporally associated with COVID-19.